The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?

Patients with Covid-19 place new challenges on the management of type 2 diabetes, including the questions of whether glucose-lowering therapy should be adjusted during infection and how to manage a return to normal care after resolution of Covid-19 symptoms. Due to the sudden onset of the pandemic,...

Descripción completa

Detalles Bibliográficos
Autores principales: Czupryniak, Leszek, Dicker, Dror, Lehmann, Roger, Prázný, Martin, Schernthaner, Guntram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485772/
https://www.ncbi.nlm.nih.gov/pubmed/34598700
http://dx.doi.org/10.1186/s12933-021-01389-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485772/
https://www.ncbi.nlm.nih.gov/pubmed/34598700
http://dx.doi.org/10.1186/s12933-021-01389-1

Ejemplares similares